Mylan fires another shot at Cipla in generic Lipidil battle
Competition & Consumer Protection 2019-07-22 9:35 pm By Cat Fredenburgh | Melbourne
Please login to bookmark Close

Mylan has launched a lawsuit against Cipla for allegedly copying the get-up of its blockbuster cholesterol drug Lipidil, after losing a bid to block Cipla and Sun Pharma from selling generic versions of the drug while it appeals a ruling invalidating several claims of its patents.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au